Daniel F.
Donovan
(Dan)

Providing advice and counsel with respect to congressional oversight activity to the leading pharmaceutical industry trade association and to leading companies in the healthcare, pharmaceutical, medical device, accounting, defense, energy, food, and insurance industries.

Representing a variety of clients in connection with investigations relating to allegations of government fraud, food and product safety and recalls, product pricing, clinical research, off-label promotion, direct-to-consumer advertising, payments to physicians, and financial conflicts of interest.

Representing multiple pharmaceutical companies in connection with congressional and state attorneys general drug pricing investigations.

Representing Pfizer Inc. in connection with congressional investigations.

Representing Toyota in investigations and hearings by the House Energy and Commerce Committee, the House Oversight and Government Reform Committee, and the Senate Commerce, Science and Transportation Committee relating to allegations of unintended acceleration and recalls of certain vehicles with Takata air bag inflators.

Representing a variety of clients on healthcare policy and legislative issues.

Represented a major university and pharmaceutical company in connection with the Select Panel on Infant Lives (authorized under the House Energy and Commerce Committee) investigation relating to fetal tissue research.

Represented a global financial institution in connection with an investigation by the Senate Permanent Subcommittee on Investigations, regarding international tax matters.

Represented a Big Four accounting firm in a Senate Finance Committee investigation of a University’s handling of federal funds.

Represented multiple pharmaceutical companies in House and Senate investigations related to Affordable Care Act enactment and implementation.

Represented medical device companies in connection with House and Senate committee investigations into 510(k) regulatory issues, direct-to-consumer advertising, and payments to physicians.

Represented a leading clean energy technology company in connection with a Senate investigation into Department of Energy grant program.

Represented a major oil company in connection with congressional investigations.

Represented a health insurer in House and Senate investigations related to Affordable Care Act implementation.

Represented a coalition of food product companies in connection with congressional inquiries relating to food safety and regulatory issues.

Represented a medical society in connection with Senate committee investigations in payments to physicians.

Represented individuals in connection with House and Senate committee inquiries and ethics investigations.